Sanofi-Aventis (France), Vical Incorporated Limb Ischemia Drug NV1FGF Fails in Late-Stage Test

Sept. 22 (Bloomberg) -- Sanofi-Aventis SA said a drug that had showed promise in restoring blood vessel growth in damaged limbs was no better than a placebo in an advanced test.